It has been a mixed year for Nutex Health Inc. insiders: $148,000 bought by five people and $43,000 sold by one, so more buying than selling overall.
Biggest single buyer: Bates Jon Christian, CFO, with roughly $103,000. Notably, at least one C-suite executive was among the buyers.
Zooming out by quarter: Last full quarter: net selling by insiders. Insiders bought in 3 of the last 7 full quarters. Big money check: 154 institutions held NUTX as of Q2 2026, and more funds bought than sold.
| Filed | Insider | Role | Type | Shares | Price | Value | Source |
|---|---|---|---|---|---|---|---|
| Sep 18, 2026 | Saunders Scott J | Director | Sell | 203 | $214.25 | $43K | SEC |
| Mar 23, 2026 | Hosseinion Warren | President | Buy | 252 | $94.07 | $24K | SEC |
| Mar 23, 2026 | Jaumot Frank E | Director | Buy | 150 | $93.56 | $14K | SEC |
| Mar 18, 2026 | Spears Kelvin | Director | Buy | 10 | $94.46 | $945 | SEC |
| Mar 16, 2026 | Montgomery Pamela W. | Executive Officer | Buy | 79 | $88.87 | $7K | SEC |
| Nov 28, 2025 | Bates Jon Christian | CFO | Buy | 750 | $136.71 | $103K | SEC |
| Apr 14, 2025 | Bates Jon Christian | CFO | Buy | 1,000 | $81.81 | $82K | SEC |
| Aug 26, 2024 | Bates Jon Christian | CFO | Buy | 1,350 | $21.46 | $29K | SEC |
| Aug 21, 2024 | DeTillio Joshua | COO | Buy | 1,300 | $17.85 | $23K | SEC |
| Aug 21, 2024 | DeTillio Joshua | COO | Buy | 575 | $17.40 | $10K | SEC |
| Jun 13, 2024 | DeTillio Joshua | COO | Buy | 20,000 | $0.54 | $11K | SEC |
| May 30, 2024 | Vo Thomas T. | CEO | Buy | 3,768 | $0.68 | $3K | SEC |
| May 30, 2024 | Vo Thomas T. | CEO | Buy | 48,394 | $0.70 | $34K | SEC |
| May 30, 2024 | Vo Thomas T. | CEO | Buy | 17,330 | $0.69 | $12K | SEC |
| May 30, 2024 | Vo Thomas T. | CEO | Buy | 2,986 | $0.66 | $2K | SEC |
In the last 12 months Nutex Health Inc. insiders made open-market purchases worth about $148,000 and sales worth about $43,000. Data comes from SEC Form 4 filings, updated every 30 minutes on CapitalSnitch.
The most recent open-market insider trade in NUTX was filed on 2026-09-18.
154 investment managers reported holding NUTX in SEC Form 13F filings for Q2 2026.
No congressional trades in NUTX were reported in the past two years. The full list is free on CapitalSnitch.
Public-record data for research and education, not investment advice. Insider sales are often pre-planned (10b5-1). Congress data: Data derived from public disclosures filed under the Ethics in Government Act and the STOCK Act, republished free for public transparency and news reporting. Disclosures may lag the trade by 45 days or more and show amounts only as ranges. This data may not be used for credit rating, loan underwriting, solicitation of money (political, charitable or other), direct-mail or commercial targeting (5 U.S.C. 13107).